John R. Horn, PharmD, FCCP and Philip D. Hansten, PharmD
2. Regazzi MB et al. Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients. Transplant Proc. 1993;25:2732-34.
3. Muck W et al. Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporin-treated kidney transplant recipients. Clin Pharm Ther. 1999;65:251-61.
4. Griffith RS et al. Effect of probenecid on the blood levels and urinary excretion of cefamandole. Antimicrob Agents Chemother. 1977;11:809-12.
5. Kimura H et al. Metformin isa superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. Drug Metab Pharmacokinet. 2005;20:379-86.
6. Somogyi A et al. Reduction of metformin renal tubular secretion by cimetidine in man. Br J Clin Pharmacol.1987;23:545-51.
7. Wang ZJ et al. OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine. Pharmacogenet Genomics. 2008;18:637-45.
8. Windle J et al. Pharmacokinetic and electrophysiologic interaction of amiodarone and procainamide. Clin Pharmacol Ther. 1987,41:603-10.
9. Bauer LA et al. Levofloxacin and ciprofloxacin decrease procainamide and n-acetylprocainamide renal clearances. Antimicrob Agents Chemother. 2005;49:1649-51.
10. Somogyi A et al. Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs. Eur J Clin Pharmacol. 1983;25:339-45.